CABINET CHAILLOT
PATENTS TRADEMARKS DESIGNS
French Patent & Trademark Attorneys - European Patent Attorneys - Representatives before EUIPO
ISO 9001 CERTIFIED
Opposition division maintained European patent No. 2 785 807 ("the patent") in its form modified on the basis of the auxiliary request 1. Opponent 2 ("appellant") appealed this decision.The appellant requested that document...[more]
The appeal of the applicant (appellant) lies from a decision of an examining division, refusing the European patent application No. 09 757 250.7 with the title "Pestivirus replicons providing an RNA-based viral vector...[more]
This decision concerns the appeal filed by the opponent (appellant) against the opposition division's interlocutory decision which held the European patent in an amended form.Claim 1 of the main request, which the opposition...[more]
European patent No. 2 522 717 is based on European patent application No. 12 160 789.9, entitled "Oligopeptide-free cell culture media", filed as a divisional application of the earlier European patent application No. 07702574.0...[more]
Montenegro loses its status of extension state and becomes, as of 01/10/2022, a new full member of the EPC, bringing the number of EPC member states to 39.[more]
Korean patent office follows JPTO, USPTO, CIPO and INPI (Brazil) with which INPI already has a PPH agreement[more]
European patent 2 451 486 ("the patent") was granted with independent claim 1 relating to:"A conjugate for use in medicine, the conjugate comprising an L-asparaginase from Erwinia chrysanthemi having at least 90% identity to...[more]
Appeals have been filed by the opponent and the patent proprietor against the opposition division’s interlocutory decision to maintain European patent No. 2 170 949 in amended form according to auxiliary request 2. Claim 1 of...[more]
European patent 2 790 657 was granted with claim 1 as follows:"1. Cosmetic composition for coating keratinous fibres of the emulsion type, comprising:- an aqueous phase,- at least one wax, and- an emulsifying system...[more]
The European patent No. 2 322 153 was granted with a set of 11 claims. Claim 1 as granted reads as follows:1. A compound that inhibits hypoxia inducible factor (HIF) hydroxylase activity for use in treating or preventing iron...[more]
Commission Regulation (EU) 2022/720 of 10 May 2022 enters into force on 01/06/2022 to replace Regulation (EU) 330/2010.See press release here[more]
The appeal by the patent proprietor lies against the decision of the opposition division revoking European patent No. 2 686 382.Claim 1 of the main request reads as follows:"1. Propylene random copolymer composition...[more]
European patent 2 429 486 was granted with independent claim 1 relating to:"Process for preparing a crosslinked gel of at least one polysaccharide or one of its salts, comprising at least the steps that consist in:a)...[more]
An appeal was lodged by the patent proprietor (appellant) against the decision of the opposition division revoking European patent No. 2 074 141 ("the patent"). The patent is entitled "Protease resistant insulin analogues".In...[more]
Three oppositions were filed against the granted patent No. 2277050.The opposition division decided that the patent could be maintained as amended on the basis of the second auxiliary request filed during oral proceedings...[more]
The theme for this year is IP and Youth: Innovating for a Better Future.See WIPO dedicated webpage here.[more]
Brazilian patent office follows JPTO, USPTO and CIPO with which INPI already has a PPH agreement[more]
Appeals were filed by the patent proprietor (appellant I) and by the opponent (appellant II) against the opposition division's interlocutory decision that European patent No. 2 373 154, entitled "Barley and malt-derived beverages...[more]
The decision under appeal is the opposition division's decision rejecting the eight oppositions filed against European patent No. 2 269 604.The patent in suit stems from European patent application 10 1749 85.1, which was filed...[more]
The new version of Guidelines for Examination applicable as from March 1st, 2022 are available here.[more]
The EPO has decided to introduce two measures to support access to the Unitary Patent.[more]
EPO published in Official Journal of January 2022 the new amounts of official fees applicable as of April 1st, 2022.See the new amounst here[more]
Acceptance of DAS Codes[more]
The deposit by Austria of its instrument of ratification launched entry into force of the Protocol to the Agreement on a Unified Patent Court on provisional application (PPA).[more]
Communication by EPO of the certificate for a European patent[more]
CIPO joins USPTO and JPTO with which INPI already has a PPH agreement[more]
USPTO follows JPTO with which INPI already has a PPH agreement[more]
Slovenian government deposited its instrument of ratification for the Protocol on the Provisional Application of UPC Agreement on 15/10/2021.UPC could soon enter its set-up phase if a last country (probably Austria by end of...[more]
New norm ST.26 for sequence listings in patent applications will enter into force on 01/01/2022.It will be compatible with International Nucleotide Sequence Database Collaboration (INSDC) database provider...[more]
The Enlarged Board of Appeal (EBA) recently issued its decision G4/19 relating to double patenting[more]
The Ideas Powered for Business SME Fund is a 20 million Euro grant scheme created to help European obtain intellectual property rights[more]
The French patent office just launched an accelerated procedure to grant applications dealing with COVID-19[more]
The GCC (comprising Saudi Arabia, Bahrein, Koweit, Oman, United Arab Emirates and Qatar) stops accepting new patent applications.[more]
A delay for entry into force of unitary patent system is to be expected[more]